Cipher Capital’s Halozyme HALO Stock Holding History

Cipher Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,904	Closed	-$218K	–	512
2023 Q4	$218K	Buy	+5,904	New	+$222K	0.07%	411

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Cipher Capital's HALO Position: Q1 2024 in Review

Cipher Capital sold out of Halozyme (HALO) in Q1 2024, closing a stake of 5,904 shares — an estimated $218K sold.

Cipher Capital first reported a position in HALO in Q4 2023 and held it in 1 quarter. The position peaked at $218K in Q4 2023. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.

Cipher Capital reported no remaining Halozyme position as of Q1 2024 after selling out during the quarter.
Cipher Capital sold 5,904 Halozyme shares in Q1 2024, an estimated $218K.
Cipher Capital first reported a position in Halozyme in Q4 2023 and held it in 1 quarter.
Cipher Capital's Halozyme position peaked at $218K in Q4 2023.
414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.